STAT+: Gene-editing startup launches with $230 million and a Chinese licensing deal
A new gene-editing startup negotiated contracts with a Chinese company, raised $230 million in funding, and executed a reverse-merger with a preexisting biotech company.
All sources
- STAT News · Center
Prism News is a free news aggregator that breaks every story into Left, Center and Right perspectives — see what each side covers, what they ignore, and how the same event gets framed differently.